FAIR LAWN, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Vyteris Holdings (Nevada), Inc. today announced that Vincent De Caprio, Ph.D., President and Chief Executive Officer, will present at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference in New York City on Monday, November 7, 2005 at 3:30 p.m. ET.
A live webcast of the presentation can be accessed at http://wsw.com/webcast/rrshq7/vyhn.ob/ and through the Company’s website at www.vyteris.com, under the investor relation’s events tab. The webcast will be archived for 90 days.
About Vyteris
Vyteris Holdings (Nevada), Inc. is a specialty pharmaceutical company organized to develop and manufacture pharmaceutical products based upon its advanced drug delivery technology. The Company’s Actyve(TM) transdermal drug delivery (iontophoresis) technology delivers drugs comfortably through the skin using low-level electrical energy. This technology allows precise dosing, thus providing physicians and patients with control in the rate, dosage and pattern of delivery. The Company’s LidoSite(TM) product provides dermal analgesia prior to venipuncture (IV catheter insertions, blood draws, etc.) and superficial dermatological procedures. LidoSite(TM) received marketing clearance from the U.S. Food and Drug Administration and is marketed by B. Braun Medical Inc. For more information visit www.vyteris.com.
LidoSite(TM) is a trademark of B. Braun Medical, Inc.
Actyve(TM) is a trademark of Vyteris Holdings (Nevada), Inc.
Vyteris Holdings (Nevada), Inc.
CONTACT: Michael G. McGuinness, Chief Financial Officer, Vyteris Holdings(Nevada), Inc., +1-201-703-2418; Melody A. Carey (investors), RxCommunications Group, LLC, +1-917-322-2571, mcarey@rxir.com
Web site: http://www.vyteris.com/
